TransCode publishes preclinical data on glioblastoma treatment

Go back to TransCode publishes preclinical data on glioblastoma treatment
(NASDAQ: RNAZ) Delayed: 4.59 +0.37 (8.77%)
Previous Close $4.22    52 Week High
Open $4.38    52 Week Low
Day High $4.72    P/E N/A 
Day Low $4.38    EPS
Volume 2,958